Mind Medicine (MindMed) Inc. Share Price Deutsche Boerse AG
Equities
MMQ
CA60255C8850
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.673 EUR | +3.25% | +7.68% | +156.80% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 678M 633M 54.16B |
---|---|---|---|---|---|
Net income 2024 * | -94M -87.81M -7.51B | Net income 2025 * | -106M -99.02M -8.47B | EV / Sales 2024 * | - |
Net cash position 2024 * | 184M 172M 14.73B | Net cash position 2025 * | 99.5M 92.94M 7.95B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.94
x | P/E ratio 2025 * |
-6.43
x | Employees | 57 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.64% |
Latest transcript on Mind Medicine (MindMed) Inc.
1 day | +3.25% | ||
1 week | +7.68% | ||
Current month | +1.52% | ||
1 month | -3.66% | ||
3 months | +137.17% | ||
6 months | +264.82% | ||
Current year | +156.80% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | - | 13/01/21 |
Schond Greenway
DFI | Director of Finance/CFO | 52 | 22/05/22 |
Miri Wernli
PSD | President | 71 | 27/02/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andreas Krebs
BRD | Director/Board Member | 66 | 28/09/21 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 10/08/22 |
David Gryska
BRD | Director/Board Member | 68 | 20/06/23 |
Date | Price | Change | Volume |
---|---|---|---|
02/05/24 | 8.69 | +3.45% | 0 |
30/04/24 | 8.4 | +2.44% | 150 |
29/04/24 | 8.2 | +4.26% | 37 |
26/04/24 | 7.865 | +0.13% | 0 |
25/04/24 | 7.855 | -3.02% | 253 |
Delayed Quote Deutsche Boerse AG, May 02, 2024 at 07:12 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+46.79% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- MNMD Stock
- MMQ Stock